Good news Gaj.
Wonder what Gileads price tag will be on it?

So, greediad has a presence on twitter.......

Ty Gaj
This is exciting the news we were hoping for, phew! A drug that appears to
I have been lobbying, yes Gilead is all over Twitter and so are many hep activists!
Anyway here's the pipeline so far on this drug

hepatitiscnewdrugresearch.com/updates-so...atasvir-gs-5816.html

May have been posted elsewhere on the forum and apologies if I am doubling up citations if that's the case

Hi again I simply can't seem to post a graph
Here's another link from today's social media

www.hepmag.com/blog/epclusa-newest-hepatitis-c-treatment

Mike if you already popped this up elsewhere sorry

The Business Wire link quotes Gilead’s CEO as saying:

“Today’s approval represents a significant advance for patients with HCV genotypes 2 and 3, who previously required more complex and costly regimens,” said John Milligan, Ph.D., President and Chief Executive Officer of Gilead. “As the first and only pan-genotypic cure for hepatitis C, Epclusa has the potential to eliminate the need for genotype testing, which can be a barrier to treatment in certain resource-constrained settings. We look forward to making Epclusa available to patients around the world as quickly as possible.” See:

www.businesswire.com/news/home/201606280...es-Gilead’s-Epclusa®

Generic Darvoni (SOF 400mg + DCV 60mg) was the first and only pan-genotypic cure for HCV(until now), see:

fixhepc.com/forum/media-news/1053-darvoni-story.html

Therefore, Epclusa (SOF + VEL) is the second pan-genotypic cure … the first to be FDA approved … only because Gilead (SOF) and Bristol-Myres Squibb (DCV) didn’t want to work together and share profits. It’s all about trying to corner the market with a one pill cure all. In other words, it’s all about maximising profits, NOT about maximising the number of HCV sufferers being cured.

Epclusa may be an advancement for difficult to cure GT3s, however, it is NOT a significant advancement for GT2s who have a very high clearance rate taking Generic SOF + DCV on this forum. All you need is Darvoni for approximately USD700 + shipping & handling for a 12 week treatment. See:

www.darvoni.com/

Knowledge is power. Knowledge shared is power multiplied.”
Robert Noyce

Cheers
GT2

Yes GT2, keep pounding that drum! I've been pounding it for months now and I can't understand why journalists have to be so lazy as to not do a little research and instead simply accept a company's press release as gospel.

Velpatasvir may be slightly better, and it is definitely good to have alternatives for the few who need it, but Gilead's repeated statements that this is the first pan-genotypic solution are a form of deception. I wish some writer for some major news outlet would have the balls to say so.

Another one cures all DAA to hit the market shame the USD $74000 price tag means that the majority of the worlds 150 million HCV population will have a shit show in hell to get a hold of this pill. Just as well there are generic's out there right now that do the same thing for approx $1300 USD for a 12 week treatment.

OMG, you gotta love that there is already talk of a generic version of this drug coming soon!

Says at the bottom author is a Gilead shareholder. Fun and games in the boardrooms, really putting their minds to pricing:
www.pantagraph.com/business/investment/m...7d-00eb484768a9.html